[go: up one dir, main page]

EA199800650A1 - Новые соединения - Google Patents

Новые соединения

Info

Publication number
EA199800650A1
EA199800650A1 EA199800650A EA199800650A EA199800650A1 EA 199800650 A1 EA199800650 A1 EA 199800650A1 EA 199800650 A EA199800650 A EA 199800650A EA 199800650 A EA199800650 A EA 199800650A EA 199800650 A1 EA199800650 A1 EA 199800650A1
Authority
EA
Eurasian Patent Office
Prior art keywords
optionally substituted
lower alkoxy
substituted
oxo
hydroxy
Prior art date
Application number
EA199800650A
Other languages
English (en)
Inventor
Масааки Матсуо
Кацуо Окумура
Синдзи Сигенага
Хироаки Нисимура
Хироси Матсуда
Дайдзиро Хагивара
Тадаси Терасака
Original Assignee
Фудзисава, Фармасьютикал Ко., Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9601235.6A external-priority patent/GB9601235D0/en
Priority claimed from AUPO1111A external-priority patent/AUPO111196A0/en
Application filed by Фудзисава, Фармасьютикал Ко., Лтд filed Critical Фудзисава, Фармасьютикал Ко., Лтд
Publication of EA199800650A1 publication Critical patent/EA199800650A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Настоящее изобретение относится к новым производным тиазолилбензофурана формулы (I):где Rпредставляет низший алкил; L представляет одинарную связь или низший алкилен, необязательно замещенный арилом, оксо или гидрокси; и Q представляет гетероциклическую группу, необязательно замещенную одним или несколькими подходящими заместителями; или низший алкокси, замещенный арилом, который замещен одним или несколькими подходящими заместителями, по меньшей мере, один из которых представляет низший алкокси, необязательно замещенный циано, защищенным карбокси, карбокси, низшим алкиленом, гетероциклической группой, необязательно замещенной оксо, или амидино, необязательно замещенным гидрокси или низшим алкокси, или их солям, которые обладают активностью в качестве антагонистов или ингибиторов лейкотриена и SRS-A.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800650A 1996-01-22 1997-01-17 Новые соединения EA199800650A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9601235.6A GB9601235D0 (en) 1996-01-22 1996-01-22 Novel compounds
AUPO1111A AUPO111196A0 (en) 1996-07-18 1996-07-18 Novel compounds
PCT/JP1997/000073 WO1997027190A1 (en) 1996-01-22 1997-01-17 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
EA199800650A1 true EA199800650A1 (ru) 1999-02-25

Family

ID=25645218

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800650A EA199800650A1 (ru) 1996-01-22 1997-01-17 Новые соединения

Country Status (12)

Country Link
US (1) US5994378A (ru)
EP (2) EP0880519B1 (ru)
JP (1) JP2000503984A (ru)
KR (1) KR19990076788A (ru)
CN (1) CN1209809A (ru)
AT (2) ATE216384T1 (ru)
CA (1) CA2244189A1 (ru)
DE (2) DE69712042T2 (ru)
EA (1) EA199800650A1 (ru)
ES (1) ES2171878T3 (ru)
HU (1) HUP9900424A2 (ru)
WO (1) WO1997027190A1 (ru)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9919413D0 (en) * 1999-08-18 1999-10-20 Zeneca Ltd Chemical compounds
AU7962200A (en) * 1999-10-29 2001-05-14 Wakunaga Pharmaceutical Co., Ltd Novel indole derivatives and drugs containing the same as the active ingredient
JP4073786B2 (ja) * 2001-04-16 2008-04-09 田辺三菱製薬株式会社 高コンダクタンス型カルシウム感受性ｋチャネル開口薬
MXPA04001258A (es) 2001-08-10 2005-06-06 Nippon Chemiphar Co Activador para el receptor d que responde al proliferador de peroxisoma.
DE60232739D1 (de) 2001-10-12 2009-08-06 Nippon Chemiphar Co Aktivator des peroxisomproliferator-aktivierten rezeptors delta
CA2573185A1 (en) * 2004-07-14 2006-02-23 Ptc Therapeutics, Inc. Methods for treating hepatitis c
RU2403240C2 (ru) * 2004-10-12 2010-11-10 Декод Дженетикс Ехф Сульфонамидные пери-замещенные бициклы для лечения окклюзионного поражения артерий
WO2006046683A1 (en) * 2004-10-25 2006-05-04 Astellas Pharma Inc. Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
GB2431927B (en) * 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
CN101460458A (zh) * 2006-02-15 2009-06-17 阿勒根公司 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
AU2007214434B2 (en) * 2006-02-15 2012-06-14 Allergan, Inc. Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
RU2435764C2 (ru) 2006-04-18 2011-12-10 Ниппон Кемифар Ко., Лтд. АГЕНТ, АКТИВИРУЮЩИЙ РЕЦЕПТОР, АКТИВИРУЕМЫЙ ПРОЛИФЕРАТОРАМИ ПЕРОКСИСОМ δ
DE102006021733A1 (de) * 2006-05-09 2007-11-22 Bayer Healthcare Ag 3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung
CN101490045A (zh) * 2006-05-16 2009-07-22 解码遗传Ehf公司 7-(丙烯酰基)吲哚的制备方法
DE102006043443A1 (de) * 2006-09-15 2008-03-27 Bayer Healthcare Ag Neue aza-bicyclische Verbindungen und ihre Verwendung
US8524917B2 (en) 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
CA2674946A1 (en) * 2007-01-11 2008-07-24 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
AU2009236877B2 (en) 2008-04-15 2014-01-23 Nippon Chemiphar Co., Ltd. Activator for peroxisome proliferator-activated receptor
US8546431B2 (en) 2008-10-01 2013-10-01 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
DE102008063992A1 (de) 2008-12-19 2010-09-02 Lerner, Zinoviy, Dipl.-Ing. Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
NZ705058A (en) 2010-03-12 2016-10-28 Omeros Corp Pde10 inhibitors and related compositions and methods
EP2655362A1 (en) 2010-12-22 2013-10-30 Abbvie Inc. Hepatitis c inhibitors and uses thereof
AU2014220801A1 (en) 2013-02-21 2015-09-10 Adverio Pharma Gmbh Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
NZ716494A (en) 2014-04-28 2017-07-28 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
NZ716462A (en) 2014-04-28 2017-11-24 Omeros Corp Optically active pde10 inhibitor
CA2959501C (en) 2014-08-29 2023-10-10 Chdi Foundation, Inc. Probes for imaging huntingtin protein
CN107530313A (zh) 2015-04-24 2018-01-02 奥默罗斯公司 Pde10抑制剂以及相关组合物和方法
CA3003611C (en) 2015-11-04 2022-11-01 Omeros Corporation Solid state forms of a pde10 inhibitor
JP7006990B2 (ja) 2017-11-17 2022-02-10 セリックス バイオ プライヴェート リミテッド 眼障害の処置のための組成物及び方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2600644B2 (ja) * 1991-08-16 1997-04-16 藤沢薬品工業株式会社 チアゾリルベンゾフラン誘導体
JPH07179856A (ja) * 1993-12-21 1995-07-18 Canon Inc 液晶性化合物、これを含有する液晶組成物、該液晶組成物を用いた液晶素子並びにこれらを用いた表示方法、表示装置

Also Published As

Publication number Publication date
HUP9900424A2 (hu) 1999-05-28
DE69728581D1 (de) 2004-05-13
EP0880519B1 (en) 2002-04-17
WO1997027190A1 (en) 1997-07-31
KR19990076788A (ko) 1999-10-15
US5994378A (en) 1999-11-30
EP1170009B1 (en) 2004-04-07
EP0880519A1 (en) 1998-12-02
DE69712042D1 (de) 2002-05-23
EP1170009A3 (en) 2002-01-16
ATE263561T1 (de) 2004-04-15
CA2244189A1 (en) 1997-07-31
ES2171878T3 (es) 2002-09-16
EP1170009A2 (en) 2002-01-09
JP2000503984A (ja) 2000-04-04
CN1209809A (zh) 1999-03-03
DE69712042T2 (de) 2002-10-02
ATE216384T1 (de) 2002-05-15

Similar Documents

Publication Publication Date Title
EA199800650A1 (ru) Новые соединения
EA199800051A1 (ru) Производные бензамида и их применение в качестве антагонистов вазопрессина
EA200100310A1 (ru) Кислородсодержащие гетероциклические соединения
EP1157998A4 (en) HETEROCYCLIC COMPOUNDS, YOUR INTERMEDIATE PRODUCTS AND ELASTASE INHIBITORS
YU12992A (sh) 2-amino-1,2,3,4,-tetrahidronaftaleni supstituisani u prstenu
NO20002589D0 (no) Bifenylamidinderivater
ES551274A0 (es) Un procedimiento para la sintesis de derivados de imidazol.
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
DE69922009D1 (de) Imidazolverbindungen und ihre verwendung als adenosindeaminase-inhibitoren
DK0641770T3 (da) Hidtil ukendte forbindelser med blodpladeaggegationsinhiberende aktivitet
DE3682215D1 (de) Organische verbindungen und ihre pharmazeutische verwendung.
TR200003652T2 (tr) Glisin antagonistleri olarak tetrahidrokuinolin türevleri.
ID25477A (id) Turunan-turunan spiropiperidin
YU62801A (sh) Derivati 4-heterociklilsulfonamidil-6-metoksi-5-(2-metoksi- fenoksi)-2-piridil- piridimina, njihovo dobivanje i primena kao antagonisti endotelinskih receptora
ES2093838T3 (es) Inhibidor de fosfolipasa a2.
DE69221634D1 (de) 5-Piperazinylalkyl)-1,5-Benzothiazepinone verwendbar als Calciumantagonisten
TR200002803T2 (tr) MRP1 inhibe etmek için yöntemler.
DE3764277D1 (de) 6-ketoprostaglandin-e1-derivate.
DE68923320D1 (de) Derivate von Aminsäuren.
TR200002804T2 (tr) MRP1 inhibe etmek için yöntemler
ATE151750T1 (de) 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
ATE259346T1 (de) Benflumentolderivative und ihre verwendung gegen parasitäre protozoen und trematoden
GEP19981168B (en) Benzimidazole derivatives and pharmaceutically acceptable salts thereof, intermediate compounds, method of their reception, stable crystals, a composition for inhibition of angiotensin ii